The expression dysregulation of PDIA3 has been assessed in several gastrointestinal cancers, and PDIA3 over-expressions in gastric carcinoma and colon cancer have been proven (Ren et al., 2006; Yang et al., 2018; Shimoda et al., 2019). This evidence concerns the gene PDIA3 and colonic neoplasm.